Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Tianhong Li, MD, PhD
University of California, Davis
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California at Davis Cancer Center
Sacramento, California, United States
Recruiting - Uf Health Cancer Center, University of Florida
Gainesville, Florida, United States
Recruiting - Adventhealth Medical Group Oncology Research at Celebration
Kissimmee, Florida, United States
Recruiting - Norton Cancer Center
Louisville, Kentucky, United States
Recruiting - Rogel Cancer Center, University of Michigan
Ann Arbor, Michigan, United States
Recruiting - Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, United States
Recruiting - Md Anderson Cancer Center
Houston, Texas, United States
Recruiting - Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Aug 2024
- Primary completion
- 30 Sept 2027
- Completion
- 30 Sept 2027
- Last update posted
- 25 Jun 2026
- Registered enrollment
- 72
- Registry id
- NCT06352359
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.